Regeneron Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript
All right. Good morning, everyone. My name is Cory Kasimov, I'm the senior large-cap biotech analyst at JPMorgan. And it's my pleasure to introduce Regeneron, one of my favorite presentations every week at this conference. We have another 2 for one special with both CEO, Len Schleifer; and CSO, George Yancopoulos. And please note that following the presentation there is a breakout across the hall in the [Borgia] rooms.
With that, I'll turn it over first to Len. Thank you.
Thank you, Cory. I wish your favoritism would show up in your ratings. Anyways, no, it is good to be here.
Let's see. Our favorite slide. You take a look at this. This is on our website. There's a lot of things I might say here that I might regret and this should cover some of those sins.
It's fun to look back a decade ago, given that this is the beginning of the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |